Cannara Biotech

What Cannara Biotech does

Cannara Biotech Inc. (TSX: LOVE; OTCQX: LOVFF; FRA: 8CB) is a publicly traded Canadian cannabis producer incorporated in British Columbia in 2018 and headquartered in Saint-Laurent, Quebec. The company operates two mega indoor and hybrid greenhouse cultivation facilities in Quebec — a 170,000 sq. ft. site in Farnham (completed 2019) and a 600,000 sq. ft. hybrid indoor/greenhouse site in Salaberry-de-Valleyfield (built 2020, on 3 million sq. ft. of land) — spanning a combined footprint of over 1.65 million sq. ft. with up to 100,000 kg of annualized production capacity.

Cannara's cultivation technology is built around full environmental automation: LED lighting, automated irrigation, room-by-room HVAC, biomonitoring sensors, robotics, and closed-loop air, water, and nutrient systems. These systems are intended to drive consistency, yield, and cost efficiency, and are paired with a dedicated R&D function focused on genetic selection (pheno-hunting, rare strains) and continuous process improvement. The product portfolio spans dried flower, pre-rolls, cannabis oils, and (since November 2024) vape products, marketed under three registered brands: Tribal (premium rare genetics), Nugz (value bulk formats), and Orchid CBD (CBD-rich specialty).

The business model is B2B sales through Canadian provincial cannabis retailers — SQDC in Quebec (where Cannara holds #1 retail market share at 14.3% as of Q2 FY2026) is the primary channel, supplemented by OCS (Ontario), BC Cannabis Stores, and boards in Saskatchewan and Manitoba. Cannara positions as premium craft quality at disruptive pricing, leveraging Quebec's low electricity and labor costs to sustain industry-leading 29% EBITDA margins and record 45% gross margins while reporting 19 consecutive quarters of positive Adjusted EBITDA. FY2025 revenue reached a record $107.3 million, the first year of positive retained earnings, and the company is executing a CAD 30 million capex plan to double Valleyfield capacity by fiscal 2030 alongside the May 2026 acquisition of Medican Organic Inc.

Name

Cannara Biotech

Legal name

Cannara Biotech Inc.

Website

https://cannara.ca

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

Cannara Biotech is a publicly traded Canadian cannabis producer (TSX: LOVE) operating two mega indoor and hybrid greenhouse facilities in Quebec spanning 1.65 million sq. ft. with up to 100,000 kg of annualized cultivation capacity, selling premium, value, and CBD products under Tribal, Nugz, and Orchid CBD brands through provincial cannabis retailers across Canada.

Ownership category

akta.pro rank

Product category

Cannabis Cultivation and Production

NAICS

Medicinal and Botanical Manufacturing (325411), Tobacco Manufacturing (31223)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Adult-Use (Recreational) Cannabis Dispensaries (CRANAFAA)

akta.pro secondary industries

Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Cannabis Accessories & Ancillary Products Wholesale (Vapes, Packaging, Hardware) (CRAOAIAH)

Keywords

• Indoor cannabis cultivation
• Cannabis brand portfolio
• Medical and recreational cannabis
• Cannabis cultivation facilities
• Cannabis production and processing

Headquarters

HQ city

Saint Laurent

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Cannabis Product Sales: Cannara generates revenue through the sale of premium cannabis products including dried flowers, pre-rolls, cannabis oils, and vape products. The company sells through provincial retailers across Canada, with Quebec as the primary market. Both retail and wholesale channels contribute to revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Cannara Biotech is a vertically integrated Canadian cannabis producer that cultivates, processes, and sells premium cannabis products including dried flowers, pre-rolls, cannabis oils, and vape products. The company operates two mega indoor and hybrid greenhouse facilities in Quebec spanning over 1.6 million square feet with up to 100,000 kg of annualized production capacity, leveraging full automation, biomonitoring, and closed-loop HVAC systems. Products are marketed under three consumer brands (Tribal, Nugz, Orchid CBD) and sold wholesale and through provincial cannabis retailers across Canada.

Product overview

Cannara Biotech is a vertically integrated Canadian cannabis company operating two mega cultivation facilities in Quebec spanning over 1,650,000 square feet with up to 100,000 kg of annualized production capacity. The company offers a portfolio of cannabis products including dried flowers, pre-rolls, cannabis oils, and vape products, distributed under three distinct consumer brands: Tribal (premium rare genetics), Nugz (premium value bulk formats), and Orchid CBD (CBD-rich products). The company leverages advanced automated cultivation technology including LED lighting, climate control, irrigation, and robotics to produce craft-quality cannabis at disruptive pricing for both recreational and medical markets across Canada.

Differentiator

Problem solved

Functional benefit

Brands

• Tribal: Premium quality cannabis brand delivering uncompromised products to users with a deep relationship with cannabis. Features rare genetics, slow cured and hand trimmed dried cannabis flower with rotating strains.
• Nugz
• Orchid CBD

Products and services

• Tribal Premium cannabis brand offering rare-genetics dried flower that is hang dried, slow cured, and hand trimmed; sold through provincial retailers for adult recreational and medical consumers seeking craft quality.
• Nugz Value-focused cannabis brand sold in bulk formats only, offering oversized nugs in 28g bags and fourteen 0.6g pre-roll packs targeting long-time consumers seeking premium quality at disruptive pricing.
• Orchid CBD CBD-focused cannabis brand offering rare genetics of CBD-rich, terpene-rich, trichome-covered oversized dried flowers and pre-rolls for softer, blissful experiences in both recreational and medical markets.
• Dried Cannabis Flower Premium dried cannabis flower cultivated from rare genetics, hang dried, slow cured, and hand trimmed; the foundational product category serving both recreational and medical Canadian cannabis consumers.
• Pre-rolls Pre-rolled cannabis products available in multiple pack sizes, including 0.6g individual pre-rolls and 14-pack formats, made from premium hand-trimmed cannabis flower.
• Cannabis Oils Cannabis oil products derived from Cannara's cultivation operations, serving both recreational and medical cannabis markets across Canada.
• Cannabis Vape Products Vape cartridges and products launched in Quebec in November 2024, formulated to comply with Quebec's 30% THC cap, expanding Cannara's product portfolio beyond traditional flower products.

Quantifiable outcome

• 14.3% retail market share in Quebec - #1 position
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Medican Organic Inc.coreStrategic or Co-development Partner · 6 May 2026Cannara completed acquisition of Medican Organic Inc., expanding the company's operations and cultivation capabilities. The acquisition represents strategic growth through M&A.
• Exotic GenetixminorStrategic or Co-development Partner · 4 August 2022Exclusive brand partnership with Exotic Genetix to bring Exotic Mike's famous cannabis genetics to the Canadian market, expanding Cannara's product offerings with exotic strains.

Scale indicators17 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Canopy Growth Corporation: Largest Canadian licensed cannabis producer with national distribution across all provincial boards. Comparable as a publicly traded Canadian LP selling premium and value-tier cannabis through SQDC, OCS, and other provincial retailers, though materially larger and more diversified than Cannara.
• Tilray Brands: Major Canadian cannabis producer with diversified brand portfolio and broad provincial distribution. Directly comparable as a publicly traded LP serving the same provincial retail channels and competing for shelf space in Quebec and other provinces.
• Aurora Cannabis: Canadian licensed producer with cultivation facilities and national distribution. Comparable as a Canadian LP selling dried flower, pre-rolls, oils, and vapes through provincial boards, competing for the same retail shelf space as Cannara.
• Cronos Group: Canadian licensed producer with cultivation, brand portfolio, and provincial distribution. Comparable as a publicly traded Canadian LP selling premium cannabis products through provincial boards.

Direct peers

• OrganiGram Holdings: Mid-cap Canadian LP focused on premium indoor-grown cannabis and value formats. Closely comparable to Cannara in product strategy (premium craft and bulk value tiers), GTM through provincial retailers, and focus on margin discipline and EBITDA positivity.
• Auxly Cannabis Group: Canadian cannabis company with cultivation, branded products, and national distribution through provincial retailers. Cannara's VP Sales previously led sales at Auxly, reflecting direct operational overlap as a peer competing in the same provincial channels.
• HEXO Corp: Canadian LP with Quebec heritage and a strong share position in SQDC. Closely comparable to Cannara as a Quebec-focused producer competing head-to-head for SQDC shelf space and Quebec market share.
• Village Farms International: Canadian LP leveraging large-scale greenhouse cultivation technology for premium cannabis. Comparable to Cannara in its emphasis on advanced controlled-environment agriculture, automation, and craft-quality flower at scale for the Canadian market.
• Decibel Cannabis Company: Canadian cannabis producer focused on premium craft flower and value formats sold through provincial retailers. Comparable to Cannara in product mix (dried flower, pre-rolls), branding strategy, and reliance on Western Canadian provincial boards for distribution.
• Sundial Growers: Canadian licensed cannabis producer with cultivation and branded products distributed through provincial boards. Comparable as a small/mid-cap Canadian LP with similar product categories and provincial distribution model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Cannarabiotech
• Facebookfacebook.com/cannarabiotech
• LinkedInlinkedin.com/company/cannarabiotech
• Instagraminstagram.com/cannarabiotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds9 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannara Biotech